SureTrader Advertisement Advertisement Advertisement
Home > Boards > US OTC > Medical - Drugs >

Ocata Therapeutics Inc. (OCAT)

Add OCAT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator elysse1kittycat, sports guy, LODE MAKING ME RICH, homeslice10, lasers, AyeEye
Search This Board:
Last Post: 10/3/2015 8:27:02 PM - Followers: 650 - Board type: Free - Posts Today: 0

 Ocata Therapeutics (OCAT)

formerly Advanced Cell Technology (ACTC):
Advanced Cell Technology Changes Name to Ocata Therapeutics

Ocata Therapeutics Headquarters
33 Locke Drive
Marlborough, MA 01752
Tel: (508) 756-1212
Fax: (508) 229-2333 

Company Overview

Ocata Therapeutics, Inc. (“Ocata”; NASDAQ: OCAT), formerly named Advanced Cell Technology, is a clinical stage biotechnology company focused on the development and commercialization of new therapies in the field of regenerative medicine. Regenerative medicine is defined as the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function and has been called the “next evolution of medical treatments” and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.

The company’s principal R&D and commercial efforts relate to its Regenerative Ophthalmology™ programs and involve development of therapies for the treatment of eye diseases and disorders. Beyond the eye, our other research areas include projects focusing on developing many different cell therapies that may be used to treat a range of diseases across several therapeutic categories. Ocata’s principal laboratory, GMP facility and corporate offices are in Marlborough, Massachusetts. 

Regenerative Ophthalmology Platform

The mission behind our Regenerative Ophthalmology efforts is clear. It is our goal to bring innovative new therapies to the market to treat diseases of the eye that otherwise may cause significant loss of vision in patients. Our emerging cell therapies focus on structural repair and functional restoration and have the potential to make a significant difference in the lives of people with ocular disorders.

We are at the forefront of developing new therapies to address some of the most significant unmet medical needs in eye diseases. These include potential treatments for diseases affecting the retina, such as age-related macular degeneration – as well as other forms of macular degeneration, diabetic retinopathy and retinitis pigmentosa, as well as inflammatory diseases such as uveitis, and vision loss from photoreceptor and other neurosensory retinal damage due to glaucoma.

  • Our lead clinical program involves RPE Cell Therapy for treating macular degeneration. Critical to the development and the rate of progression of macular degeneration is the health status of the retinal pigment epithelium, or RPE, a single layer of cells whose presence and integrity in the retina are required for normal vision. The company is currently conducting clinical trials in the U.S. andU.K. for treating Stargardt’s macular degeneration with the RPE Cell Therapy, and in the U.S. for treating patients with dry age-related macular degeneration.
    We are developing a Photoreceptor Progenitor Cell Therapy which we intend to be used for treating a wide variety of retinal degenerations in diseases where photoreceptors malfunction and/or die.
    Our Ganglion Progenitor Cell Therapy is a preclinical candidate program. In animal models of glaucoma, the injection of these cells protects against damage of existing nerve cells as well as forms new ganglion nerve cells.
    The company is also developing therapeutic platforms using Corneal Endothelial Cells for use in treating corneal blindness.

See our Pipeline of Ophthalmology Therapies »

Other Regenerative Medicine Programs

In addition to our regenerative ophthalmology programs we have invested in other programs where we feel that we can leverage our expertise in cellular and developmental biology to generate allogeneic therapies that have the potential to improve health care in other prevalent degenerative diseases and diseases of aging. At the core of our pipeline planning are approaches intended to address large unmet medical needs with allogeneic stem cell-derived therapeutics.

Our Mesenchymal Stem Cells

Our Mesenchymal Stem Cells (MSCs) represent an “off-the-shelf” cellular therapy ready for treatment of autoimmune and inflammatory diseases in both acute and chronic settings. MSCs regulate immune and inflammatory responses, providing therapeutic potential for treating diseases characterized by the presence of an inflammatory component, which makes them an attractive tool for the cellular treatment of autoimmunity and inflammation. We believe we have succeeded at creating a differentiated MSC product by producing the cells in culture from a pluripotent stem cell source.

Neuroprotective Biologics

We have discovered Neuroprotective Biologics that are secreted by certain of our neurosensory retina progenitor cell populations. We anticipate that the neuroprotective agent(s) that we may ultimately develop as drug candidates may be useful not only in retinal diseases and dystrophies, but may have broader applications in central nervous system and peripheral nervous system diseases and disorders, including diseases causing cognitive function impairment, movement disorders such as Parkinson’s Disease, and ischemic events such as caused by stroke.

Blood Components Programs

Through our Blood Components Programs, we have been able to generate Red Blood Cells, Platelets, Dendritic cells and other cells relevant immune response or hemostasis.


Pipeline of Therapeutic Programs

Ocata’s world-class research and development programs embody our efforts to bring transformative new therapies to market for patients facing some of hardest-to-treat eye diseases and disorders.




Press Releases






All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.




Rules of the board according to IHUB:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#88104  Sticky Note I had to register just to make a comment. Enough-Already 08/26/15 05:35:48 PM
#76767  Sticky Note Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation lasers 11/24/14 12:12:44 PM
#74805  Sticky Note ACT Announces Positive Results from Two Clinical Trials LittleDutchDenny 10/14/14 09:50:43 PM
#89210   I see they are giving out more FREE fulleroots 10/03/15 08:27:02 PM
#89209   There was a separate PR by CTIX on north40000 10/02/15 09:25:20 PM
#89206   Quote LOL, "Kirk did Ocata close green? Oh Captain Kirk 10/02/15 04:25:55 PM
#89205   Kirk did Ocata close green? Oh was it King215grill 10/02/15 04:16:16 PM
#89204 Reetala 10/02/15 03:48:01 PM
#89203   Quote LOL, "If Ocata was an authentic Kachina Captain Kirk 10/02/15 02:41:43 PM
#89202   Quote BS LOL, "LOL...Great post! She is going Captain Kirk 10/02/15 02:34:06 PM
#89201   Good one Lol fulleroots 10/02/15 02:03:34 PM
#89200   LOL...Great post! She is going up man! OCAT Big_Mullet 10/02/15 01:08:25 PM
#89199   Yo Bro...look at the ticker. She is going. Big_Mullet 10/02/15 01:06:06 PM
#89198   If Ocata was an authentic Kachina doll, then AyeEye 10/02/15 12:34:20 PM
#89197   That's awesome. I am not selling. Looking forward Jbuzzhal 10/02/15 12:28:19 PM
#89196   Quote BS LOL, "the stock is GOING UP, Captain Kirk 10/02/15 11:56:36 AM
#89195   LOLWUT??????? UH OH, Friday, and it's GREEN !!!! Enough-Already 10/02/15 11:03:05 AM
#89194   Yes!!!!! Very strong buy now!!!$$$$$$ calm61 10/02/15 10:48:35 AM
#89193   Friday, and it OPENS RED, Captain Kirk 10/02/15 09:58:02 AM
#89192   Love the business side we have. R/s really sports guy 10/02/15 09:52:53 AM
#89191   Exactly kirk. OCAT has major upside. Just wait calm61 10/01/15 08:30:54 PM
#89190   Quote BS LOL, "Addressing A Major Public Need: Captain Kirk 10/01/15 07:59:23 PM
#89189   Addressing A Major Public Need: The Ocata Preclinical calm61 10/01/15 07:26:28 PM
#89188  Restored ART2426 AMD phase 2 DFRAI 10/01/15 11:46:51 AM
#89187   $3.96 is DAY'S LOW ALREADY, UH OH???? Captain Kirk 10/01/15 11:43:24 AM
#89186   Quote LOL, "Premarket PPS going off at $4.50" Captain Kirk 10/01/15 10:59:47 AM
#89185  Restored That was EXACTLY my thought when I was art2426 10/01/15 10:52:10 AM
#89184   Does anyone know why Ocata is not on too simple 10/01/15 10:45:00 AM
#89183   Beginning to believe that smokey 10/01/15 10:04:04 AM
#89182   As a person who has owned and followed elysse1kittycat 10/01/15 09:55:59 AM
#89181   That pretty much is a given on any smokey 10/01/15 09:52:40 AM
#89180   Anyone who has been around a while knows elysse1kittycat 10/01/15 09:46:04 AM
#89179   Disappointing start thought we would go over 5.00 smokey 10/01/15 09:37:29 AM
#89178   Premarket PPS going off at $4.50 lasers 10/01/15 09:29:14 AM
#89177   Actually they did lasers 10/01/15 09:26:25 AM
#89175   This is just great news Lasers. Why Shiskabill 10/01/15 08:39:57 AM
#89174   Shiskabill $OCAT official 60 persons, 3 cohort AMD lasers 10/01/15 08:17:59 AM
#89173   ALLELE IS GETTIG READY!!! Thanks OCATa!!! dsroyal91 10/01/15 07:41:30 AM
#89172   thank you Lasers as always. Glad to Shiskabill 10/01/15 07:34:15 AM
#89171   reo54 Many thxs for the feedback and most lasers 09/30/15 10:33:59 PM
#89170   Shareholder Overview for OCAT Ocata Therapeutics Inc including BigWorm129 09/30/15 10:04:04 PM
#89169   Hey Lasers, just wanted to say 'thanks' for reo54 09/30/15 09:00:33 PM
#89167   Some of You may not be members of Goodbuddy4863 09/30/15 08:29:26 PM
#89164  Restored Quote LOL, "Ocata Therapeutics Is An Official Phase Captain Kirk 09/30/15 07:07:15 PM
#89163   $OCAT New AMD Clinical Trial lasers 09/30/15 06:53:26 PM
#89162   Ocata Therapeutics Is An Official Phase 2 Biotech: lasers 09/30/15 06:35:48 PM
#89161   LOL X 100 DEAD CAT BOUNCE!!!LOL dsroyal91 09/30/15 05:01:01 PM
#89160   New SA article @ 11:10 AM gocatgo 09/30/15 04:59:54 PM
#89158   Pfizer fails to end lawsuit over Bextra, Celebrex safety lasers 09/30/15 04:27:39 PM
#89157   Even DEAD CATS bounce once in a while- Captain Kirk 09/30/15 04:14:49 PM
#89156   "solid facts" and truth...I try to find both, north40000 09/30/15 04:10:08 PM
#89155   I think solid facts scare the shorts North. Shiskabill 09/30/15 04:04:51 PM
#89153   Depend on the point of entry, It green!!! King215grill 09/30/15 03:30:53 PM